Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India. - Wikidata - wikimedia - TriplyDB

Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India.

Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India.

http://www.wikidata.org/entity/Q37221898

about

A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.

P2860

Q50225594-B9CFA1DE-76BD-4F49-BCBE-2A661A12896E

P2860

Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India.

http://www.wikidata.org/entity/Q37221898

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic Stratification of G ...... Tertiary Care Center in India.

@en

Prognostic Stratification of G ...... Tertiary Care Center in India.

@nl

type

label

Prognostic Stratification of G ...... Tertiary Care Center in India.

@en

Prognostic Stratification of G ...... Tertiary Care Center in India.

@nl

prefLabel

Prognostic Stratification of G ...... Tertiary Care Center in India.

@en

Prognostic Stratification of G ...... Tertiary Care Center in India.

@nl

P1433

Q37221898-5CE17F84-DD69-430B-AB72-4877CE1883DC

P1476

Q37221898-CA5AD732-618F-41E7-A012-EAC15FF0D7C2

P2093

Q37221898-241707E8-3CB1-440F-8FA1-F20928E97E18

Q37221898-39BB43FA-E60D-4C05-9D85-7D47D44016D6

Q37221898-53E3B7F7-9A8C-4A08-923C-27ED66244232

Q37221898-575A5B05-3575-48C3-AAB3-D9E5ADA8585E

Q37221898-5C556A4D-C29E-45B9-BBA4-837818F776A5

Q37221898-678EE01E-B050-4232-87D2-F2016E72EB06

Q37221898-870F8A97-83D2-4116-A18F-D8823C3333CE

Q37221898-A3BAECA7-C591-4B5E-9E65-4F522F2F7CA9

Q37221898-A6EFEB7E-097F-44E0-A795-0994E01F3458

Q37221898-B4EBE434-6B2C-4E45-AD44-BA3ABE4DBEA2

P2860

Q37221898-0424780E-44D6-4025-9D29-F3F3C8FB1AD3

Q37221898-1B3B0276-90A3-49B1-878D-660644D084D2

Q37221898-3222FCDC-E81C-4E37-A536-2E8F533421F6

Q37221898-35392443-1819-413D-8AF2-699B78982A7F

Q37221898-3B0ECEAC-D733-45F2-B028-257C971821C7

Q37221898-3DD0AEF3-FABE-4600-BEC4-E64FCF833C03

Q37221898-42C5F93D-0F4D-4D3D-8FAC-CB1B5D8C61F0

Q37221898-633E579E-1D2E-4931-A979-088118F628C8

Q37221898-6391F96F-3EAF-4C15-A597-64D0A5E62A17

Q37221898-68960BAE-6E44-4BE0-A259-4CEA13950CD1

P304

Q37221898-C308FFA3-17DA-4314-854D-2F91387EAE4D

P31

Q37221898-C2E0192C-AA81-4A7F-9EB3-6B6336E1706F

P356

Q37221898-2817C0E3-D4E5-43CC-87F2-18B2E1020D58

P433

Q37221898-AA785260-0979-422F-9137-A4A06B7F40A4

P478

Q37221898-90A908FA-C220-4160-93E0-CC8299A9969F

P577

Q37221898-7BB0ED05-9699-4D64-A9D7-AD8D5E670975

P698

Q37221898-8F8CBA03-9856-45F9-962D-B7C273F5DD9B

P921

Q37221898-88B70579-F353-4A02-93BE-D1416C751312

P932

Q37221898-2B0C91AE-8E8D-40AC-9C8F-48796CD5CD84

P356

J.TRANON.2016.06.005

P1433

Translational Oncology

P1476

Prognostic Stratification of G ...... Tertiary Care Center in India.

@en

P2093

Ahitagni Biswas

http://www.w3.org/2001/XMLSchema#string

Anupam Kumar

http://www.w3.org/2001/XMLSchema#string

Ashish Datt Upadhyay

http://www.w3.org/2001/XMLSchema#string

Ashish Suri

http://www.w3.org/2001/XMLSchema#string

Chitra Sarkar

http://www.w3.org/2001/XMLSchema#string

Deepak Gupta

http://www.w3.org/2001/XMLSchema#string

Mehar C Sharma

http://www.w3.org/2001/XMLSchema#string

Pankaj Pathak

http://www.w3.org/2001/XMLSchema#string

Pramod Kumar Julka

http://www.w3.org/2001/XMLSchema#string

Prerana Jha

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Highly recurrent TERT promoter mutations in human melanoma

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.

P304

371-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TRANON.2016.06.005

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27567961

http://www.w3.org/2001/XMLSchema#string

P921

P932

5006811

http://www.w3.org/2001/XMLSchema#string